RAMM fundamentals
RAMM PHARMA CORP. financial statements, including revenue, expenses, and profit
The total revenue of RAMM for the last quarter is 1.02 M CAD, and it's 15.45% lower compared to the previous quarter. The net income of Q4 24 is -11.48 M CAD.
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−12.00 M
−8.00 M
−4.00 M
0.00
4.00 M
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CAD
Q1 '20
Jan 2020
Q2 '20
Apr 2020
Q3 '20
Jul 2020
Q4 '20
Oct 2020
Q1 '21
Jan 2021
Q2 '21
Apr 2021
Q3 '21
Jul 2021
Q4 '21
Oct 2021
Q1 '22
Jan 2022
Q2 '22
Apr 2022
Q3 '22
Jul 2022
Q4 '22
Oct 2022
Q1 '23
Jan 2023
Q2 '23
Apr 2023
Q3 '23
Jul 2023
Q4 '23
Oct 2023
Q1 '24
Jan 2024
Q2 '24
Apr 2024
Q3 '24
Jul 2024
Q4 '24
Oct 2024
TTM
Total revenueYoY growth
1.33 M
+40.70%
1.26 M
+43.96%
1.33 M
+49.80%
1.15 M
−3.59%
955.25 K
−28.01%
1.16 M
−8.09%
1.21 M
−9.19%
1.02 M
−11.09%
4.34 M
−1.29 M
−1.28 M
−1.32 M
−2.07 M
−1.01 M
−1.08 M
−884.47 K
−771.79 K
−3.74 M
Gross profitYoY growth
37.96 K
+190.99%
−22.11 K
−138.54%
6.46 K
—
−925.15 K
−283.90%
−53.11 K
−239.93%
80.33 K
—
323.54 K
+4,909.91%
249.53 K
—
600.29 K
−1.78 M
−1.47 M
−1.31 M
−1.62 M
−1.42 M
−1.86 M
−1.34 M
−2.73 M
−7.35 M
Operating incomeYoY growth
−1.74 M
+11.34%
−1.49 M
+18.47%
−1.30 M
−10.64%
−2.54 M
+14.10%
−1.47 M
+15.37%
−1.78 M
−19.20%
−1.02 M
+21.93%
−2.48 M
+2.49%
−6.75 M
78.78 K
324.95 K
262.86 K
−1.30 M
−819.41 K
45.98 K
22.49 K
−8.99 M
−9.75 M
Pretax incomeYoY growth
−1.66 M
+13.62%
−1.17 M
+18.84%
−1.04 M
+9.23%
−3.84 M
+76.63%
−2.29 M
−37.99%
−1.73 M
−48.41%
−993.75 K
+4.34%
−11.47 M
−198.56%
−16.49 M
−1.66 M
−1.17 M
−1.04 M
−3.85 M
−2.29 M
−1.73 M
−993.75 K
−11.48 M
−16.50 M
Net incomeYoY growth
−1.66 M
+13.62%
−1.17 M
+18.84%
−1.04 M
+9.23%
−3.85 M
+76.58%
−2.29 M
−37.99%
−1.73 M
−48.41%
−993.75 K
+4.34%
−11.48 M
−198.02%
−16.50 M
−1.66 M
−1.17 M
−1.04 M
−3.85 M
−2.29 M
−1.73 M
−993.75 K
−11.48 M
−16.50 M
Basic earnings per share (Basic EPS)YoY growth
−0.01
+12.82%
−0.01
+17.95%
−0.01
+7.53%
−0.03
+75.97%
−0.02
−41.18%
−0.01
−51.04%
−0.01
+3.49%
−0.10
−197.83%
−0.14
Diluted earnings per share (Diluted EPS)YoY growth
−0.01
+12.82%
−0.01
+17.95%
−0.01
+7.53%
−0.03
+75.97%
−0.02
−41.18%
−0.01
−51.04%
−0.01
+3.49%
−0.10
−197.83%
−0.14
122.30 M
121.80 M
120.68 M
119.39 M
119.39 M
119.39 M
119.39 M
119.39 M
—
122.30 M
121.80 M
120.68 M
119.39 M
119.39 M
119.39 M
119.39 M
119.39 M
—
EBITDAYoY growth
−1.41 M
+23.92%
−1.06 M
+33.59%
−953.54 K
−14.99%
−2.32 M
+11.94%
−1.16 M
+17.42%
−1.47 M
−38.30%
−710.19 K
+25.52%
−2.20 M
+5.08%
−5.54 M
EBITYoY growth
−1.74 M
+11.34%
−1.49 M
+18.47%
−1.30 M
−10.64%
−2.54 M
+14.10%
−1.47 M
+15.37%
−1.78 M
−19.20%
−1.02 M
+21.93%
−2.48 M
+2.49%
−6.75 M
−3.07 M
−2.75 M
−2.63 M
−3.69 M
−2.43 M
−2.94 M
−2.22 M
−3.50 M
−11.09 M